Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents.

Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents.

AIMS: To provide insight on the patients with long lesions that received multiple, overlapping stents by reporting clinical outcomes, together with a detailed angiographic and intravascular ultrasound analysis of the overlap zone. METHODS AND RESULTS: TAXUS VI is a prospective, multicentre, double-b...

Full description

Bibliographic Details
Main Authors:	Dawkins, K, Grube, E, Guagliumi, G, Banning, A, Zmudka, K, Colombo, A, Thuesen, L, Hauptman, K, Marco, J, Wijns, W, Popma, J, Weissman, N, Koglin, J, Russell, M
Format:	Journal article
Language:	English
Published:	2007

Similar Items

Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
by: Dawkins, K, et al.
Published: (2005)

TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions.
by: Grube, E, et al.
Published: (2007)

TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions.
by: Grube, E, et al.
Published: (2009)

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions.
by: Colombo, A, et al.
Published: (2003)

Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study.
by: Aoki, J, et al.
Published: (2005)

Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.
by: Tanabe, K, et al.
Published: (2005)

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
by: Porto, I, et al.
Published: (2005)

Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions.
by: Silber, S, et al.
Published: (2009)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Comparison of the Absorbable Polymer Sirolimus-Eluting Stent (MiStent) to the Durable Polymer Everolimus-Eluting Stent (Xience) (from the DESSOLVE I/II and ISAR-TEST-4 Studies)
by: Lansky, Alexandra J., et al.
Published: (2018)

Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.
by: Banning, A, et al.
Published: (2010)

Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.
by: Meredith, I, et al.
Published: (2013)

Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.
by: Meredith, I, et al.
Published: (2013)

Influence of Elongation of Paclitaxel-Eluting Electrospun-Produced Stent Coating on Paclitaxel Release and Transport through the Arterial Wall after Stenting
by: Zhanna K. Nazarkina, et al.
Published: (2021-04-01)

Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency
by: Rory Marples, MBBS, et al.
Published: (2022-01-01)

Calcified nodule progression-related stent thrombosis after polymer-based paclitaxel-eluting nitinol stent implantation for femoropopliteal artery
by: Tatsuya Nakama, MD, et al.
Published: (2021-09-01)

Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock.
by: Chun-Tai Mao, et al.
Published: (2019-01-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
by: Guillaume Marquis-Gravel, et al.
Published: (2017-09-01)

Use of Paclitaxel Eluting Stents in Arteriovenous Fistulas: A Pilot Study
by: Krystal Dinh, et al.
Published: (2019-12-01)

Drug deposition in coronary arteries with overlapping drug-eluting stents
by: Olgac, Ufuk, et al.
Published: (2017)

The Twelve-Month Outcome of Biolimus Eluting Stent with Biodegradable Polymer Compared With an Everolimus Eluting Stent with Durable Polymer
by: Ahmad Separham, et al.
Published: (2011-11-01)

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
by: Ryota Kakizaki, et al.
Published: (2020-10-01)

Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent
by: Litsky J, et al.
Published: (2014-05-01)

Safety of MRI early after implantation of a drug-eluting stent.
by: Porto, I, et al.
Published: (2004)

Everolimus-eluting stents: update on current clinical studies
by: Allocco DJ, et al.
Published: (2011-07-01)

A randomized multicentre study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: The BELLO (Balloon Elution and Late Loss Optimization) study
by: Suraj Khanal
Published: (2013-03-01)

High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis
by: Blackman, D, et al.
Published: (2003)

Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents.
by: Da Hyon Lee, et al.
Published: (2017-01-01)

Efficacy and safety of biodegradable polymer biolimus-eluting stents versus durable polymer drug-eluting stents: a meta-analysis.
by: Yicong Ye, et al.
Published: (2013-01-01)

THE EFFECTS OF CLINICAL, LABORATORY, AND ANGIOGRAPHIC FACTORS ON STENT THROMBOSIS AND MAJOR ADVERSE CARDIAC EVENTS IN PACLITAXEL ELUTING STENTS
by: Kandemir Caglayan Hasan, et al.
Published: (2023-05-01)

Head-to-head comparison of sirolimus-eluting stents versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of 76 studies.
by: Xinlin Zhang, et al.
Published: (2014-01-01)

Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome.
by: Mack, M, et al.
Published: (2011)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
by: Alaide Chieffo, et al.
Published: (2007-09-01)

Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents
by: Juan F. Iglesias, et al.
Published: (2019-11-01)

Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
by: Juntao Yin, et al.
Published: (2023-01-01)

Thrombotic occlusion of a drug-eluting stent - is IVUS mandatory.
by: Arnold, JR, et al.
Published: (2006)

Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
by: Blackman, D, et al.
Published: (2004)

Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial.
by: Tsuchida, K, et al.
Published: (2007)

First-in-man use of polymer-free valsartan-eluting stents in small coronary vessels: a comparison to polymer-free rapamycin (2%)-eluting stents
by: Stefan Peters, et al.
Published: (2009-06-01)

The effect of paclitaxel-eluting covered metal stents versus covered metal stents in a rabbit esophageal squamous carcinoma model.
by: Yin Zhang, et al.
Published: (2017-01-01)